Longform / 23andMe 23andMe Has Gone From Hot to Not. Can Its CEO Save It? Stocks are trading below $1, but Anne Wojcicki sees promise in drug development By Kate Seamons Posted Jan 31, 2024 11:15 AM CST Copied Back